Precision Business Insights has published a report on the global cancer gene therapy market, estimating its value at USD 3,341.6 Million in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 24.3% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/global-cancer-gene-therapy-market

The cancer gene therapy market refers to the industry focused on developing and commercializing gene-based treatments for cancer. These therapies involve modifying or introducing genetic material into a patient's cells to combat cancer by either inhibiting tumor growth, inducing cell death, or enhancing the immune system's ability to fight cancerous cells.

Drivers:

• Rising Cancer Cases: The increasing global prevalence of cancer is fuelling demand for innovative treatments.
• Advancements in Gene Therapy: Breakthroughs in genetic engineering and biotechnology are making gene therapy a viable alternative to traditional cancer treatments.

The global cancer gene therapy market segmentation:

1)By Therapy Type: Gene Induced Immunotherapy, Oncolytic Virotherapy, Gene Transfer
2)By End-User: Hospitals and Clinics, Biopharma and Biotechnology Companies, Academic and Research Institutes, Others

Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=16156

Regional Overview:

The report also examines the current concerns and their Future Effects on the cancer gene therapy market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the cancer gene therapy market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.

• North America (U.S., Canada)
• Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
• Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
• Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

The competitive landscape is dominated by major players like Urigen Pharmaceuticals Inc., GenVec Inc., Oxford BioMedica, Vical, ANI Pharmaceuticals Inc., Genzyme Corporation, Novartis AG, Cell Medica, Cell Genesys Inc., Adaptimmune Therapeutics plc, Genelux Corporation.

About Precision Business Insights:

We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com 
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/  | D U N S® Number: 852781747